Michael H. Kroll
YOU?
Author Swipe
View article: Automated Natural Language Processing to Identify Venous Thromboembolism from Diagnostic Imaging Reports
Automated Natural Language Processing to Identify Venous Thromboembolism from Diagnostic Imaging Reports Open
View article: Impact of homologous recombination deficiency on CDK4/6 inhibitor sensitivity in HR+/HER2-breast cancer
Impact of homologous recombination deficiency on CDK4/6 inhibitor sensitivity in HR+/HER2-breast cancer Open
While the combination of endocrine therapy (ET) and CDK4/6 inhibitors (CDK4/6i) improves progression-free survival (PFS) in HR+/HER2- metastatic breast cancer, resistance remains a major challenge. BRCA2 pathogenic variants have been linke…
View article: Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study
Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study Open
View article: Abstract No. 180 Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study
Abstract No. 180 Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study Open
View article: Checkpoint inhibitors
Checkpoint inhibitors Open
Immune checkpoint inhibitors are a class of antineoplastic therapies that unleash immune cells to kill malignant cells. These medications commonly cause immune-related adverse effects due to activated adaptive and innate immune cells, auto…
View article: OC 36.1 External Validation of Novel Electronic Health Record (EHR) Risk Model for Cancer Associated Thrombosis in a Comprehensive Cancer Center
OC 36.1 External Validation of Novel Electronic Health Record (EHR) Risk Model for Cancer Associated Thrombosis in a Comprehensive Cancer Center Open
View article: Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism
Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism Open
Background Patients with gastrointestinal cancer (GICA) are at high risk for venous thromboembolism (VTE). Data from randomized clinical trials in cancer-associated VTE suggest that direct oral anticoagulants (DOACs) conferred similar or s…
View article: Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease Open
View article: External validation of a novel electronic risk score for cancer‐associated thrombosis in a comprehensive cancer center
External validation of a novel electronic risk score for cancer‐associated thrombosis in a comprehensive cancer center Open
Venous thromboembolism (VTE) is a significant complication for cancer patients undergoing systemic therapy. We performed an independent external validation for a recently derived and validated a novel electronic health record (EHR) VTE ris…
View article: Thrombosis in hereditary hemorrhagic telangiectasia
Thrombosis in hereditary hemorrhagic telangiectasia Open
View article: Measurement of Adherence and Health-related Quality of Life during Anticoagulation Therapy in Cancer Associated-Venous Thromboembolism (VTE): A Multicenter Quantitative Study
Measurement of Adherence and Health-related Quality of Life during Anticoagulation Therapy in Cancer Associated-Venous Thromboembolism (VTE): A Multicenter Quantitative Study Open
Purpose Therapy for cancer associated-venous thromboembolism (VTE) includes long term anticoagulation, which may have substantial impact on the health-related quality of life (HRQL) of patients. We assessed patient-reported outcomes to cha…
View article: Single Cell Clonotypic and Transcriptional Evolution of Multiple Myeloma Precursor Disease
Single Cell Clonotypic and Transcriptional Evolution of Multiple Myeloma Precursor Disease Open
View article: Hematologic complications of immune checkpoint inhibitors
Hematologic complications of immune checkpoint inhibitors Open
Immune checkpoint inhibitors are a class of antineoplastic therapies that unleash immune cells to kill malignant cells. There are currently 7 medications that have been approved by the US Food and Drug Administration for the treatment of 1…
View article: Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography
Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography Open
Objectives: To evaluate the role of platelet count and thromboelastogram (TEG) in the treatment of thrombocytopenic cancer patients with suspected coronary artery disease (CAD). Background: Cancer patients with CAD and thromb…
View article: The AHR: adaptive evolution or one-off?
The AHR: adaptive evolution or one-off? Open
View article: Early detection of transformation to BPDCN in a patient with MDS
Early detection of transformation to BPDCN in a patient with MDS Open
View article: A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia
A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia Open
Ibrutinib is highly efficacious and used at 420 mg/d for treatment of chronic lymphocytic leukemia (CLL). We previously demonstrated a decline in Bruton’s tyrosine kinase (BTK) protein levels in CLL cells after 1 cycle of ibrutinib, sugges…
View article: Development of a predictive model for 6 month survival in patients with venous thromboembolism and solid malignancy requiring IVC filter placement
Development of a predictive model for 6 month survival in patients with venous thromboembolism and solid malignancy requiring IVC filter placement Open
View article: Platelets are not hyperreactive in patients with ovarian cancer
Platelets are not hyperreactive in patients with ovarian cancer Open
Paraneoplastic thrombocytosis has been reported in different types of solid tumors, including ovarian epithelial cancer, and found to be associated with a worse outcome. Although the effect of cancer on increasing platelet counts is well d…
View article: Pretreatment Complete Blood Count Improves Prognostic Model Survival Prediction in Oropharyngeal Cancer Patients Treated With Radiation Therapy
Pretreatment Complete Blood Count Improves Prognostic Model Survival Prediction in Oropharyngeal Cancer Patients Treated With Radiation Therapy Open
View article: Hematology
Hematology Open
—stress (Gaisböck's syndrome), decreased intravascular volume
View article: Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation
Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation Open
The purpose of this study is to evaluate potential associations between increased platelets and oncologic outcomes in oropharyngeal cancer patients receiving concurrent chemoradiation. A total of 433 oropharyngeal cancer patients (OPC) tre…
View article: Efficacy of an IVC filter retrieval algorithm in a cancer population
Efficacy of an IVC filter retrieval algorithm in a cancer population Open